Magnite Stock News

Thrivent Financial for Lutherans raised its stake in Magnite, Inc. (NASDAQ:MGNI) by 96.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 240,970 shares of the companys stock after buying an additional 118,464 shares during the quarter. Thrivent Financial for Lutherans holdings in Magnite were worth $8,154,000 as of its most recent SEC filing. []

The AdTech industry has seen a lot of volatility and jostling for second position throughout 2021. Magnite seemed to be the clear second to The Trade Desk earlier this year valuation wise, but they ha

Magnite, Inc. (NASDAQ:MGNI) insider Adam Lee Soroca sold 20,000 shares of Magnite stock in a transaction that occurred on Wednesday, December 1st. The shares were sold at an average price of $18.23, for a total transaction of $364,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through []

Magnite Inc. (NASDAQ:MGNI) traded at $17.63 at close of the session on Tuesday, 11/30/21, made a downward move of -4.13% on its previous days price. Looking at the stock we see that its previous close was $18.39 and the beta (5Y monthly) reads 2.39 with the days price range being $17.07 $18.72. The company Magnite Inc. (NASDAQ: MGNI) Analysts Revisions Show Sentiment Is Improving Read More »

Leon Siotis appointed as SpringServes Head of International

Shares of Magnite, Inc. (NASDAQ:MGNI) have earned a consensus rating of Buy from the thirteen brokerages that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12 month target price among analysts that have []

Health Catalyst (NASDAQ:HCAT) and Magnite (NASDAQ:MGNI) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk. Profitability This table compares Health Catalyst and Magnites net margins, return on equity and return on []

Price T Rowe Associates Inc. MD raised its position in shares of Magnite, Inc. (NASDAQ:MGNI) by 3.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,718 shares of the companys stock after buying an additional 1,860 shares during the period. Price T Rowe []

KLDiscovery (OTCMKTS:KLDI) and Magnite (NASDAQ:MGNI) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Analyst Recommendations This is a breakdown of current ratings and recommmendations for KLDiscovery and Magnite, as provided []

Analysts expect that Magnite, Inc. (NASDAQ:MGNI) will announce earnings of $0.26 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Magnites earnings. Magnite reported earnings per share of $0.19 during the same quarter last year, which indicates a positive year over year growth rate of 36.8%. The []

This company has more top-tier customers than its rivals in the space.

It's a tight race, highlighting the intense competition in the supply side of ad tech.

Kopion Asset Management LLC lifted its stake in shares of Magnite, Inc. (NASDAQ:MGNI) by 12.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 186,791 shares of the companys stock after buying an additional 20,975 shares during the quarter. Magnite makes up []

Magnite will serve as primary SSP connecting advertisers with premium inventory distributed across the vMVPDs channels Magnite will serve as primary SSP connecting advertisers with premium inventory distributed across the vMVPDs channels

Related Stocks: ABST , MGNI , HMTV , CURI , CURI ,